4
Changes in Ownership
Drugs Made In America Acquisition Corp. Filed Acc 0001213900-25-010193
CEO and Executive COB bought 400,000 shares
- CEO and Executive COB sold 5,698,363 shares
- CEO and Executive COB disposed of 400,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stockwell Lynn CEO and Executive COB | 2025-01-29 | Purchase | +400,000 | 10,257.14 | I | ||
| Stockwell Lynn CEO and Executive COB | 2025-01-29 | Other disposition | −400,000 | 9,857,143 | I | ||
| Stockwell Lynn CEO and Executive COB | 2025-01-29 | Sale | −5,698,363 | 4,158,780 | I | ||
| Derivatives | |||||||
| Stockwell Lynn CEO and Executive COB | 2025-01-29 | Purchase · Rights to receive ordinary shares | +400,000 | 400,000 | I | ||
| Open-market purchases · 400,000 sh | |||||||
| Open-market sales · 5,698,363 sh | |||||||
Loading xslF345X05/ownership.xml…